SOL Strategies reports a net loss of $3.5 million in Q2 2025, with a surge in staking and validation revenue
Odaily Planet Daily News: Canadian globally publicly listed company, SOL Strategies, which focuses on Solana infrastructure, recorded a net loss of $3.5 million in the second quarter of 2025, despite significant growth in its staking and validation revenue.
The financial report shows that the company's Q2 revenue reached $1.85 million, a substantial increase from $67,000 in the same period last year, mainly derived from staking and node validation rewards from Solana and Sui, including commissions from staking its own assets and third-party delegations.
As of March 31, the total value of the company's crypto assets reached $35.2 million, including newly added SUI assets, while significantly reducing BTC exposure. In April this year, SOL Strategies announced the issuance of $500 million in convertible notes and recently submitted a pre-application for a securities issuance of up to $1 billion to support its expansion strategy in the Solana ecosystem.
Despite revenue growth, its total quarterly expenditure reached $6.21 million, including $2.35 million in equity compensation and $1.85 million in amortization expenses, mainly from recent acquisitions of validator infrastructure. Additionally, it includes $710,000 in professional fees and $488,000 in interest expenses, far exceeding its crypto income. (Cointelegraph)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Blackstone (BX.US) injects up to $1.5 billion, providing fresh ammunition for Pfizer (PFE.US) in the weight-loss drug race
Pfizer announced on Wednesday that it has reached an agreement with Blackstone to obtain up to $1.5 billions in funding to support the development of its experimental monthly obesity treatment drug.
Bernstein Downgrades Nvidia Rating and Target Price

Google (GOOGL.US) DeepMind launches AlphaGenome 2: Capable of decoding DNA cells with nearly double the mutation identification capacity
Google DeepMind has released its AI model AlphaGenome 2, which is trained on maps of over 100 millions of cells and has nearly double the ability of its predecessor in identifying gene expression variations.

The White House did not intervene in the decision-making of Nvidia's board of directors.
